The Dose & Radiobiological Risk Tool is a digital decision-support and educational application designed to estimate the radiation dose received by patients from diagnostic radiological examinations such as CT, conventional X-ray, mammography, fluoroscopy, OPG, and CBCT. The tool uses examination history, modality type, anatomical region, number of repeated examinations, age, sex, and available technical parameters such as CTDIvol, DLP, KAP/DAP, kVp, mAs, and scan length to calculate approximate effective and cumulative dose.
Beyond dose estimation, the tool provides a probabilistic radiobiological risk assessment, based on internationally recognized radiation-risk models and dose–risk relationships. It does not diagnose disease or predict cancer in an individual patient. Instead, it gives an evidence-based interpretation of potential stochastic risk associated with cumulative exposure to ionizing radiation.
Integrated within the AI4MED platform, the tool can support patient education, professional awareness, research analysis, radiation protection, protocol optimization, and future development of a national patient dose monitoring framework. Its main purpose is to promote safer, justified, and optimized use of radiological imaging.
We kindly invite medical professionals to participate in our research study by completing the survey through the link below. Your professional opinion will help us better understand radiological practices before, during, and after the COVID-19 pandemic, and will contribute to the development of improved solutions for patient safety, dose monitoring, and radiological protection. [Click here to participate in this survey]
